Inovalon Holdings, Inc. (INOV) Income Statement Analysis

See more : Zephyr Minerals Ltd. (ZPHYF) Income Statement Analysis – Financial Results

Complete financial analysis of Inovalon Holdings, Inc. (INOV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Inovalon Holdings, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.

You may be interested

Inovalon Holdings, Inc. (INOV)

Industry: Medical - Healthcare Information Services

Sector: Healthcare

Website: http://www.inovalon.com

About Inovalon Holdings, Inc.

Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.

Metric	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	667.52M	642.41M	527.68M	449.36M	427.59M	437.27M	361.54M	295.80M	300.28M	239.69M
Cost of Revenue	167.82M	167.81M	144.83M	151.05M	159.17M	146.14M	112.76M	120.05M	101.19M	102.70M
Gross Profit	499.70M	474.60M	382.85M	298.31M	268.42M	291.13M	248.78M	175.74M	199.09M	136.99M
Gross Profit Ratio	74.86%	73.88%	72.55%	66.39%	62.78%	66.58%	68.81%	59.41%	66.30%	57.15%
Research & Development	33.50M	33.69M	28.64M	27.38M	29.15M	22.33M	23.13M	21.19M	15.50M	14.86M
General & Administrative	216.62M	200.76M	205.04M	149.95M	137.28M	115.03M	88.57M	80.64M	72.66M	63.18M
Selling & Marketing	62.94M	62.41M	45.53M	34.10M	27.08M	14.68M	7.14M	5.95M	6.79M	6.75M
SG&A	279.56M	263.17M	250.57M	184.05M	164.35M	129.71M	95.71M	86.59M	79.45M	69.94M
Other Expenses	114.93M	108.25M	96.73M	53.09M	37.28M	22.63M	19.88M	15.52M	12.90M	11.23M
Operating Expenses	427.99M	405.11M	375.94M	264.52M	230.79M	174.68M	138.72M	123.30M	107.85M	96.02M
Cost & Expenses	595.81M	572.92M	520.76M	415.57M	389.95M	320.82M	251.48M	243.35M	209.04M	198.72M
Interest Income	479.00K	2.24M	2.18M	5.43M	5.79M	3.00M	6.00K	9.00K	11.00K	10.00K
Interest Expense	56.18M	65.83M	50.90M	6.23M	5.07M	4.42M	1.34M	79.00K	129.00K	62.00K
Depreciation & Amortization	114.93M	108.25M	96.73M	53.09M	37.28M	22.63M	19.88M	15.52M	12.90M	11.23M
EBITDA	186.56M	179.96M	94.07M	91.90M	81.25M	141.76M	129.95M	67.97M	104.15M	52.21M
EBITDA Ratio	27.95%	28.01%	17.83%	20.45%	19.00%	32.42%	35.94%	22.98%	34.68%	21.78%
Operating Income	71.71M	69.49M	6.92M	33.79M	37.63M	116.46M	110.06M	52.45M	91.24M	40.97M
Operating Income Ratio	10.74%	10.82%	1.31%	7.52%	8.80%	26.63%	30.44%	17.73%	30.38%	17.09%
Total Other Income/Expenses	-56.25M	-63.61M	-60.47M	-1.20M	1.27M	-1.75M	-1.33M	-70.00K	-118.00K	-52.00K
Income Before Tax	15.46M	5.88M	-53.56M	32.59M	38.90M	114.71M	108.73M	52.38M	91.12M	40.92M
Income Before Tax Ratio	2.32%	0.91%	-10.15%	7.25%	9.10%	26.23%	30.07%	17.71%	30.34%	17.07%
Income Tax Expense	-7.12M	-1.90M	-14.39M	-2.23M	11.80M	48.65M	43.38M	19.66M	35.96M	15.99M
Net Income	22.58M	7.78M	-39.16M	34.82M	27.10M	66.06M	65.35M	32.72M	55.16M	24.93M
Net Income Ratio	3.38%	1.21%	-7.42%	7.75%	6.34%	15.11%	18.08%	11.06%	18.37%	10.40%
EPS	0.15	0.05	-0.27	0.24	0.18	0.45	0.53	1.47	2.48	1.12
EPS Diluted	0.15	0.05	-0.27	0.24	0.18	0.45	0.53	1.47	2.48	1.12
Weighted Avg Shares Out	149.72M	148.63M	145.39M	142.23M	150.05M	145.75M	122.26M	22.22M	22.22M	22.22M
Weighted Avg Shares Out (Dil)	149.72M	148.63M	145.39M	142.74M	150.96M	148.28M	122.26M	22.22M	22.22M	22.22M

Inovalon Recognizes Innovators Driving Healthcare Excellence with the 2024 Impact Awards

October 29, 2024globenewswire.com

Winners Recognized at the Annual Empower Conference for their Outstanding Achievements and Commitments to Advancing Healthcare Economics and Outcomes Across Three Categories Winners Recognized at the Annual Empower Conference for their Outstanding Achievements and Commitments to Advancing Healthcare Economics and...

Inovalon's Payer Cloud Ranked #1 in 2024 By Black Book Research

September 17, 2024globenewswire.com

Health Insurance Organizations Nationwide Rank Inovalon's Payer Cloud as Top Payer Technology and Data Platform for Fourth Consecutive Year Health Insurance Organizations Nationwide Rank Inovalon's Payer Cloud as Top Payer Technology and Data Platform for Fourth Consecutive Year

Inovalon's Converged Quality Achieves 24th Consecutive NCQA HEDIS® Certification

July 18, 2024globenewswire.com

The Company's Solutions are Trusted by the Health Plans Representing 80% of all U.S. Covered Lives to Deliver HEDIS Results on Time, Improving Clinical Quality and Member Outcomes The Company's Solutions are Trusted by the Health Plans Representing 80% of...

Inovalon and MEDITECH Collaborate to Transform and Optimize Revenue Cycle

June 28, 2024globenewswire.com

SaaS Healthcare Leader Joins MEDITECH Alliance to Optimize Patient Intake and Payment Processes SaaS Healthcare Leader Joins MEDITECH Alliance to Optimize Patient Intake and Payment Processes

New Study From Inovalon and Genentech Finds Racial Disparities In Emergency Department Visits For Liver Cancer Care

June 25, 2024globenewswire.com

Research Reveals How Social Drivers of Health Influence Higher Rates of Emergency Department Utilization for Black and Hispanic Hepatocellular Carcinoma Patients Research Reveals How Social Drivers of Health Influence Higher Rates of Emergency Department Utilization for Black and Hispanic Hepatocellular...